Cite
Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening.
MLA
de Ru, Minke H., et al. “Experiences of Parents and Patients with the Timing of Mucopolysaccharidosis Type I (MPS I) Diagnoses and Its Relevance to the Ethical Debate on Newborn Screening.” Molecular Genetics and Metabolism, vol. 107, no. 3, Nov. 2012, pp. 501–07. EBSCOhost, https://doi.org/10.1016/j.ymgme.2012.08.008.
APA
de Ru, M. H., Bouwman, M. G., Wijburg, F. A., & van Zwieten, M. C. B. (2012). Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening. Molecular Genetics and Metabolism, 107(3), 501–507. https://doi.org/10.1016/j.ymgme.2012.08.008
Chicago
de Ru, Minke H, Machtelt G Bouwman, Frits A Wijburg, and Myra C B van Zwieten. 2012. “Experiences of Parents and Patients with the Timing of Mucopolysaccharidosis Type I (MPS I) Diagnoses and Its Relevance to the Ethical Debate on Newborn Screening.” Molecular Genetics and Metabolism 107 (3): 501–7. doi:10.1016/j.ymgme.2012.08.008.